C-Reactive Protein/Albumin Ratio and Acne Vulgaris - Trial NCT06004583
Access comprehensive clinical trial information for NCT06004583 through Pure Global AI's free database. This phase not specified trial is sponsored by Ataturk University and is currently Completed. The study focuses on Acne Vulgaris. Target enrollment is 96 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Ataturk University
Timeline & Enrollment
N/A
Jan 05, 2022
May 01, 2023
Primary Outcome
CRP/albumin ratio
Summary
Objective: Acne vulgaris, an inflammatory disease, was investigated in this study with the
 claim that C-reactive protein (CRP) / albumin ratio and some hematological parameter ratios
 have the potential to be used as inflammatory markers to monitor disease severity and
 prognosis.
 
 Methods: A descriptive cross-sectional study was conducted with two groups of patients aged
 18-65 years, 61 patients diagnosed with acne vulgaris and 35 healthy control patients, and
 routine hemogram and biochemical parameters were compared. The Global Acne Severity Index was
 used to determine the severity of acne vulgaris.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06004583
Non-Device Trial